Cellero Launches New Products to Support the Fight Against COVID-19

Convalescent COVID-19 T-cells, PBMC and Plasma Now Available LOWELL, MA – July 28, 2020 – Cellero, the leading provider of donor and patient collection services, GMP-grade biomaterials, characterized immune cells, and custom research services, today announced the launch of new convalescent COVID-19 blood products to support research and vaccine development. Blood products collected from convalescent…

Key Biologics and Astarte Biologics Rebrand as Cellero and Announce Completion of Phase One of $50 Million Multi-Year Expansion Plan

New brand and expansion reflect the company’s mission to support the development and delivery of tomorrow’s treatments and cures. MEMPHIS, TN and BOTHELL, WA – May 12, 2020 – Key Biologics and Astarte Biologics, together the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today…

Key Biologics Joins the Fight Against COVID-19

Launches new program to supply blood products from COVID-19 convalescent donors LOWELL, MA and MEMPHIS, TN – April 29, 2020 – Key Biologics and Astarte Biologics, together the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today announced the launch of an IRB-approved initiative to…

Key Biologics Fills Critical Leadership Positions for High-Growth Business

Laurie Vertuccio named Director of Marketing and Rhonda Lyons named Director of Operations MEMPHIS, Tenn. and BOTHELL, Wash. — Jan. 30, 2020 — Key Biologics, the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today announced it has hired two new executives to support its recent growth…

Astarte and Key Biologics logos

Key Biologics and Astarte Biologics Merge

Includes growth equity investment from Ampersand Capital Partners MEMPHIS, TN and BOTHELL, WA – August 7, 2018 – Key Biologics has completed its merger with Astarte Biologics to create the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry. In conjunction with the merger, the new entity also received…

fresh and frozen whole leukaphereses

Key Biologics Accelerates CAR-T Research with New Leukaphereses Offerings

Also announces installation of Asymptote VIA Quad Freeze controlled-rate freezer MEMPHIS, TN, and MONTREAL QC, May 14, 2018 – Key Biologics LLC , a provider of biological raw materials and services for manufacturing cell-based therapeutics, today announced the availability of fresh and frozen whole leukaphereses from patients with hematologic malignancies; Multiple Myeloma, Non-Hodgkin Lymphoma, Chronic…